Home › Atherosclerosis › Tennessee › Chattanooga
Atherosclerosis clinical trials in Chattanooga, TN
3 studies for Atherosclerosis are looking for participants at sites in and around Chattanooga (within about 30 miles). Open a study to see who can join and how to contact the study team.
Assessing the Impact of Muvalaplin on Major Cardiovascular Events in Adults With Elevated Lipoprotein(a)
RecruitingPhase 3
- WR-Clinsearch, LLC, Chattanooga
- Erlanger Health System, Chattanooga
Combined Dose-Finding and CV Outcomes Study With CSL300 (Clazakizumab) in Adult Subjects With ESKD Undergoing Dialysis (POSIBIL6ESKD)
RecruitingPhase 2/3
- Southeast Renal Research Institute, Chattanooga
A Phase III Study of AZD0780 on Major Adverse CV Events in Patients With a History of ASCVD Events or at High Risk for a First Event
RecruitingPhase 3
- Research Site, Chattanooga
- Research Site, Chattanooga
About Atherosclerosis
Atherosclerosis is hardening and narrowing of the arteries caused by the buildup of a fatty substance called plaque. Learn about the risks and prevention.
More about Atherosclerosis on MedlinePlus
Atherosclerosis trials in other cities
- Houston, TX10 studies
- Boston, MA10 studies
- Washington, DC9 studies
- Orlando, FL8 studies
- Arlington, VA8 studies
- Hialeah, FL8 studies
- Las Vegas, NV7 studies
- Memphis, TN7 studies
- Dallas, TX7 studies
- Durham, NC7 studies
- Miami, FL7 studies
- San Diego, CA6 studies
Other studies in Chattanooga
- Non-Small Cell Lung Cancer11 studies
- Metastatic Cancer6 studies
- Myasthenia Gravis6 studies
- Ovarian Cancer5 studies
- Diabetes4 studies
- Lung Cancer4 studies
- Colorectal Cancer4 studies
- Chronic Kidney Disease4 studies
- Ischemic Stroke4 studies
- Steatotic Liver Disease4 studies
- Melanoma4 studies
- Cardiovascular Disease3 studies
From ClinicalTrials.gov, data retrieved Oct 1, 2026. Each study sets its own eligibility; the study team decides who can join.